California State Teachers Retirement System Sells 11,870 Shares of Henry Schein, Inc. $HSIC

Key Points

• California State Teachers Retirement System cut its Henry Schein stake by 9.6%, selling 11,870 shares and retaining 112,122 shares valued at approximately $9.36 million. Institutional investors collectively own 96.62% of the company.
• Henry Schein reported quarterly earnings of $1.27 per share, exceeding estimates of $1.24, while revenue rose 6.7% year over year to $3.46 billion. The company guided for fiscal 2026 EPS of $5.29–$5.39.
• Analysts maintain a generally positive outlook, with a consensus rating of “Moderate Buy” and an average price target of $92.93; recent targets range as high as $110.

California State Teachers Retirement System reduced its stake in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 9.6% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 112,122 shares of the company's stock after selling 11,870 shares during the quarter. California State Teachers Retirement System owned 0.10% of Henry Schein worth $9,364,429 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in HSIC. Operose Advisors LLC purchased a new position in Henry Schein in the 2nd quarter valued at $33,000. Syon Capital LLC raised its position in shares of Henry Schein by 73.1% during the second quarter. Syon Capital LLC now owns 4,932 shares of the company's stock worth $412,000 after purchasing an additional 2,083 shares during the period. Okabena Investment Services Inc. bought a new position in Henry Schein during the second quarter valued at approximately $209,000. New Mexico Educational Retirement Board increased its holdings in shares of Henry Schein by 4.2% during the 2nd quarter. New Mexico Educational Retirement Board now owns 4,950 shares of the company's stock worth $413,000 after purchasing an additional 200 shares during the period. Finally, Mufg Securities Americas Inc. increased its stake in shares of Henry Schein by 5.3% in the second quarter. Mufg Securities Americas Inc. now owns 2,917 shares of the company's stock valued at $244,000 after buying an additional 148 shares in the last quarter. Hedge funds and other institutional investors own 96.62% of the company's stock.

Henry Schein Trading Down 1.5%

Shares of HSIC stock traded down $1.35 during trading hours on Tuesday, reaching $87.58. 383,121 shares of the stock traded hands, compared to its average volume of 1,326,557. The firm has a market capitalization of $9.76 billion, a PE ratio of 25.54, a PEG ratio of 1.56 and a beta of 0.81. Henry Schein, Inc. has a 1-year low of $61.94 and a 1-year high of $92.18. The business has a fifty day moving average price of $87.85 and a 200 day moving average price of $80.76. The company has a quick ratio of 0.73, a current ratio of 1.32 and a debt-to-equity ratio of 0.60.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $1.27 earnings per share for the quarter, beating the consensus estimate of $1.24 by $0.03. Henry Schein had a net margin of 2.96% and a return on equity of 15.97%. The firm had revenue of $3.46 billion during the quarter, compared to analysts' expectations of $3.37 billion. During the same quarter last year, the company posted $1.10 EPS. The company's quarterly revenue was up 6.7% compared to the same quarter last year. Henry Schein has set its FY 2026 guidance at 5.290-5.390 EPS. On average, equities research analysts forecast that Henry Schein, Inc. will post 5.36 EPS for the current year.

Wall Street Analysts Forecast Growth

HSIC has been the subject of a number of recent research reports. Barrington Research set a $104.00 price objective on shares of Henry Schein in a report on Wednesday, August 5th. Barclays reissued an "overweight" rating and issued a $100.00 price target (up from $86.00) on shares of Henry Schein in a research note on Thursday, August 6th. Piper Sandler increased their target price on shares of Henry Schein from $91.00 to $95.00 and gave the stock an "overweight" rating in a report on Wednesday, July 29th. Wall Street Zen raised shares of Henry Schein from a "hold" rating to a "buy" rating in a research note on Monday, August 17th. Finally, BTIG Research lifted their price target on Henry Schein from $100.00 to $110.00 and gave the company a "buy" rating in a research report on Wednesday, August 19th. Nine analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $92.93.

Henry Schein Company Profile

Henry Schein, Inc NASDAQ: HSIC is a global provider of health care products and services for dental and medical professionals. The company distributes consumable supplies, equipment, pharmaceuticals, vaccines, and other products used by dental practices, physician offices, clinics, and other health care organizations.

In addition to product distribution, Henry Schein provides technology and business solutions designed to support practice operations. Its offerings include practice-management software, digital dentistry solutions, clinical technologies, equipment services, consulting, and other value-added services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.